Antibody induction by influenza vaccines in the elderly: a review of the literature
- PMID: 2683459
- DOI: 10.1016/0264-410x(89)90150-3
Antibody induction by influenza vaccines in the elderly: a review of the literature
Abstract
Conflicting results have been reported concerning the association between high age and response to influenza vaccines. Some authors have found a reduced response in aged subjects, others have found no difference or even better results as compared with younger control subjects. Seventeen papers were selected from international literature published in the period 1968-1988 for a review of the anti-haemagglutinin-IgG sero-response following vaccination: among 30 cases in which vaccine components could be studied independently, ten revealed a better immune response in young subjects than in the elderly, four found more favourable results in the elderly, and 16 could not detect any significant between-group-differences, the latter most probably because of a high type-2-error. Nine of these 16 cases tended to favour young subjects. These results were relativated by the finding that each paper had at least one of three methodological limitations: (1) the failure to exclude subjects with illnesses or using drugs influencing the immune system, (2) the failure to exclude subjects with previous vaccinations against influenza, (3) the failure to exclude subjects with high prevaccination antibody titres. The direction of these biases is such that failure to address any one issue will lead to an underestimate of the response of aged subjects. In view of the failure to control these biases, it was not surprising that the papers reviewed presented a heterogeneous picture. Thus, the association between high age per se and response to influenza vaccines, if any, has not yet been established. Suggestions are made for future studies in which admission criteria should control health state and previous exposure to influenza antigens.
Similar articles
-
Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature.Vaccine. 1993;11(9):892-908. doi: 10.1016/0264-410x(93)90375-8. Vaccine. 1993. PMID: 8212834 Review.
-
Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults.Vaccine. 1996 Oct;14(14):1331-9. doi: 10.1016/s0264-410x(96)00058-8. Vaccine. 1996. PMID: 9004442
-
Influenza vaccination in elderly people.Exp Gerontol. 1999 Jun;34(3):445-52. doi: 10.1016/s0531-5565(99)00007-8. Exp Gerontol. 1999. PMID: 10433399 Review.
-
A 21-winter seasons retrospective study of antibody response after influenza vaccination in elderly (60-85 years old) and very elderly (>85 years old) institutionalized subjects.Hum Vaccin Immunother. 2017 Nov 2;13(11):2659-2668. doi: 10.1080/21645515.2017.1373226. Epub 2017 Sep 18. Hum Vaccin Immunother. 2017. PMID: 28922621 Free PMC article.
-
[Specific immune response to vaccination with an inactivated flue vaccine depending on prevaccine status and age of the person vaccinated].Vopr Virusol. 2000 Mar-Apr;45(2):26-9. Vopr Virusol. 2000. PMID: 10765547 Russian.
Cited by
-
Vaccination in the elderly: an immunological perspective.Trends Immunol. 2009 Jul;30(7):351-9. doi: 10.1016/j.it.2009.05.002. Epub 2009 Jun 18. Trends Immunol. 2009. PMID: 19540808 Free PMC article. Review.
-
Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation.Clin Exp Immunol. 1998 Nov;114(2):271-6. doi: 10.1046/j.1365-2249.1998.00714.x. Clin Exp Immunol. 1998. PMID: 9822287 Free PMC article.
-
Extended antigen sparing potential of AS03-adjuvanted pandemic H1N1 vaccines in children, and immunological equivalence of two formulations of AS03-adjuvanted H1N1 vaccines: results from two randomised trials.BMC Infect Dis. 2013 Sep 16;13:435. doi: 10.1186/1471-2334-13-435. BMC Infect Dis. 2013. PMID: 24041010 Free PMC article. Clinical Trial.
-
Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccine.Vaccine. 2011 Apr 5;29(16):2865-73. doi: 10.1016/j.vaccine.2011.02.017. Epub 2011 Feb 23. Vaccine. 2011. PMID: 21352939 Free PMC article. Clinical Trial.
-
Estimation of the Effectiveness of Quadrivalent Influenza Vaccines by Distinguishing Between Influenza A (H1N1) pdm09 and Influenza A (H3N2) Using Rapid Influenza Diagnostic Tests During the 2018-2019 Season.Intern Med. 2020 Apr 1;59(7):933-940. doi: 10.2169/internalmedicine.3616-19. Epub 2019 Nov 29. Intern Med. 2020. PMID: 31787695 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical